Track 18: Epigenetics


Epigenetics refers to inherited information passed down from parent cell to daughter cell but not encoded in the DNA sequence. Some epigenetic changes are a normal part of many biological processes, but other types can lead to disease, including cancer



It is a chemical modifications of a cell’s genetic material that lead to changes in gene expression without altering the DNA sequence. Over the past few years, we have learned that epigenetic mechanisms play a critical role in the initiation, development, and progression of many types of cancer. Unlike genetic mutations, epigenetic states are in many cases reversible, which means it may be possible to manipulate them with drugs to interfere with tumor-promoting cell processes.



The goal of the CER is to explore how epigenetic processes integrate cellular signaling and the metabolic state to influence cell proliferation, differentiation, and adaptation during both normal development and cancer. This research is providing new insights into cancer pathogenesis and unique opportunities for developing new therapeutic strategies.



 



 


    Related Conference of Track 18: Epigenetics

    March 27-28, 2024

    6th International Conference on Digital Health

    London, UK
    April 24-25, 2024

    35th European Heart and Heart Failure Congress

    Paris, France
    June 21-22, 2024

    52nd Global Nursing & Healthcare Conference

    Rome, Italy
    September 09-10, 2024

    3rd Global Summit on Physiology and Metabolism of Thyroid

    Paris, France
    September 18-19, 2024

    29th International Conference on Skincare and Cosmetology

    Amsterdam, Netherlands
    September 19-20, 2024

    20th Global Biomarkers and Clinical Research Summit

    Amsterdam, Netherlands
    September 24-25, 2024

    5th Global Summit on Public Health

    Paris, France

    Track 18: Epigenetics Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in